Roche targets mid-single digit sales growth in 2025
Roche has given two early-phase bispecifics the heave-ho, ending work on a HER2xCD3 prospect and an IL-15 candidate it picked ...
After repeatedly wowing investors, Roche’s star eye med Vabysmo collected more than $4 billion in sales during its third year ...
The upscale French furniture-maker posted preliminary revenues of 414 million euros for the full year, but said its fourth ...
Wafaa Mamilli will join Roche as the company's new Chief Digital Technology Officer in February. This follows expansive roles she has held at Zoetis and at Eli Lilly.
Two Massachusetts men were indicted for COVID-19 fraud, facing charges of wire fraud conspiracy and wire fraud after allegedly filing fake unemployment claims.
Roche will continue a careful approach to high-priced deals, putting science at the center of its business development decisions, executives said Thursday.
So get your questions in now for Art and he will be with you between 4pm and 5pm GMT (11am to 12pm ET) to answer as many as he can ...
Roche’s freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used in ...
Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF290.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback